Athletes Have 59% More MOTS-c Before Anyone Injects a Thing
A small new study found that elite athletes carry about 59% more circulating MOTS-c than sedentary young men, with no injections involved. MOTS-c is a mitochondrial peptide often pitched online as an "exercise mimetic." Across 30 young males in three fitness tiers, higher levels tracked with VO2max and with lower post-exercise oxidative damage. But the design is cross-sectional with just 10 people per group, so it cannot show cause and effect, and it contains no data on injected MOTS-c. Here is what the numbers show, what they don't, and what it means if you're tempted by the vial.
CoQ10 Flunks the Muscle Test in 33 Trials of Adults Over 40
CoQ10 is one of the most popular "mitochondria" supplements for aging muscles, but a new meta-analysis of 33 randomized trials in adults 40 and older found no clearly meaningful benefit. The VO2max gain was just +0.73 mL/kg/min, with a confidence interval that includes zero. Results for walking distance, grip, leg strength, chair rise, and lean mass were also uncertain. Certainty was low or very low across key outcomes, so this is "not shown" rather than "disproven." The review also doesn't address statin users or heart failure specifically, so it's no verdict on those uses.